BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

BRG.AU

31.71

+1.96%↑

LLC.AU

6.07

+1.68%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Uždarymo kaina

SektoriusNekilnojamasis turtas

31.64 1.74

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

31.08

Max

32.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

153M

Pardavimai

951M

P/E

Sektoriaus vid.

143.238

78.251

Pelnas, tenkantis vienai akcijai

0.26

Dividendų pajamingumas

1.28

Pelno marža

16.106

Darbuotojai

6,978

EBITDA

276M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+20.64% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.28%

5.61%

Kitas uždarbis

2025-05-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-4.4B

18B

Ankstesnė atidarymo kaina

29.9

Ankstesnė uždarymo kaina

31.64

Naujienos nuotaikos

By Acuity

62%

38%

158 / 192 reitingas Real estate

Fisher & Paykel Healthcare Corp Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-03 21:55; UTC

Rinkos pokalbiai

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2025-02-02 22:06; UTC

Rinkos pokalbiai

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

2024-11-28 21:55; UTC

Rinkos pokalbiai

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

2024-11-18 22:39; UTC

Rinkos pokalbiai

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2024-09-02 23:56; UTC

Rinkos pokalbiai

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

2024-05-30 00:44; UTC

Rinkos pokalbiai
Uždarbis

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

2024-05-29 23:35; UTC

Rinkos pokalbiai

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

2024-05-28 22:43; UTC

Rinkos pokalbiai

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

2024-05-28 20:59; UTC

Uždarbis

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

2024-05-28 20:58; UTC

Uždarbis

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

2024-05-28 20:57; UTC

Uždarbis

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

2024-05-28 20:56; UTC

Uždarbis

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

2024-04-24 02:38; UTC

Rinkos pokalbiai

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

Akcijų palyginimas

Kainos pokytis

Fisher & Paykel Healthcare Corp Ltd Prognozė

Kainos tikslas

By TipRanks

20.64% į viršų

12 mėnesių prognozė

Vidutinis 36.495 AUD  20.64%

Aukščiausias 42.7 AUD

Žemiausias 31.95 AUD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fisher & Paykel Healthcare Corp Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

6 ratings

2

Pirkti

2

Laikyti

2

Parduoti

Rinkos nuotaikos

By Acuity

158 / 192 reitingas Nekilnojamasis turtas

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.